Big isn’t always best - this award recognises Dako as the small company (with a maximum 1000 antibodies in its portfolio) with the most citations.

We used the data generated through CiteAb to gain a really clear picture of the way antibodies are used around the world. We can tell which countries are investing most in research using antibodies, which companies are seeing growth or decline, which antibodies are most successful and which areas of research are seeing growth.

From the CiteAb citation data from the January - December 2015 period this award was clearly meant for Dako who had the highest number of citations over their portfolio.

Dr Andrew Chalmers, Founder of CiteAb, said “Dako stocks just over 200 antibodies, but clearly with such strong citation levels across its portfolio these are high quality products. Congratulations to the company for winning the 2016 CiteAb Small Company of the Year award!”

RUNNER UP: Active Motif

Back To Categories